Two Sigma Advisers’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $552K | Sell |
|
|||||
|
2025
Q1 | $622K | Sell |
|
|||||
|
2024
Q4 | $1.37M | Sell |
|
|||||
|
2024
Q3 | $3.25M | Sell |
|
|||||
|
2024
Q2 | $5M | Buy |
|
|||||
|
2024
Q1 | $10.6M | Sell |
|
|||||
|
2023
Q4 | $7.02M | Sell |
|
|||||
|
2023
Q3 | $4.1M | Buy |
|
|||||
|
2023
Q2 | $8.65M | Sell |
|
|||||
|
2023
Q1 | $10.7M | Buy |
|
|||||
|
2022
Q4 | $6.85M | Buy |
|
|||||
|
2022
Q3 | $1.1M | Buy |
|
|||||
|
2022
Q2 | $1.19M | Sell |
|
|||||
|
2022
Q1 | $2.89M | Sell |
|
|||||
|
2021
Q4 | $14.8M | Sell |
|
|||||
|
2021
Q3 | $26.4M | Sell |
|
|||||
|
2021
Q2 | $63.5M | Sell |
|
|||||
|
2021
Q1 | $67.9M | Buy |
|
|||||
|
2020
Q4 | $54.4M | Buy |
|
|||||
|
2020
Q3 | $14.9M | Buy |
|
|||||
|
2020
Q2 | $5.3M | Buy |
|
|||||
|
2020
Q1 | $1.62M | Sell |
|
|||||
|
2019
Q4 | $3.06M | Sell |
|
|||||
|
2019
Q3 | $3.25M | Sell |
|
|||||
|
2019
Q2 | $5.23M | Sell |
|
|||||
|
2019
Q1 | $5.91M | Sell |
|
|||||
|
2018
Q4 | $4.58M | Buy |
|
|||||
|
2018
Q3 | $4.71M | Buy |
|
|||||
|
2018
Q2 | $2.28M | Buy |
|
|||||
|
2018
Q1 | $1.69M | Buy |
|
|||||
|
2017
Q4 | $436K | Buy |
|
|||||
|
2017
Q3 | $79K | Buy |
|